This is a community-generated profile. If you work at Inotek Pharmaceuticals, to claim it.
Inotek Pharmaceuticals Funding
$0
22 rounds
Inotek Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on September 27, 2013.
Funding Rounds
D
$23600000Investors of Inotek Pharmaceuticals
Caisse de dépot et placement du Quebec
Global investment group managing funds for retirement and insurance plans
Rho Capital Partners
MedImmune Ventures
Rounds
U
Pitango Venture Capital
Rounds
U
Rho Ventures
30 Years of Investing in Innovation
Rounds
U
Care Capital
Rounds
U
Devon Park BioVentures
Rounds
U
